VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,000 | +38.5% | 786 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $13,000 | +225.0% | 786 | +322.6% | 0.01% | +200.0% |
| Q4 2017 | $4,000 | +33.3% | 186 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $3,000 | 0.0% | 186 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | +50.0% | 186 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | -60.0% | 186 | 0.0% | 0.00% | -66.7% |
| Q1 2016 | $5,000 | – | 186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |